ACTINOGEN MEDICAL LIMITED - Announcements

3.70%

2.8¢

Market Cap $90.50M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Announcements

Filter Results

All Price Sensitive Only

ACW	Investor Presentation-February 2015		17/02/15	1.06MB	Share
ACW	Investor Update-February 2015		16/02/15	5.19MB	Share
ACW	Ethics Approval Granted for Second Phase 1 Study of Xanamem	PRICE SENSITIVE	16/02/15	106.82KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/15	89.07KB	Share
ACW	Employee Share Plan Vesting Conditions Met		16/01/15	88.05KB	Share
ACW	US Investor Presentation-January 2015		09/01/15	1.63MB	Share
ACW	Resonse to ASX Query - Price Query	PRICE SENSITIVE	07/01/15	137.48KB	Share
ACW	Final Director's Interest Notice		18/12/14	18.57KB	Share
ACW	Appendix 3X-Dr Bill Ketelbey		18/12/14	66.02KB	Share
ACW	Actinogen Board Changes	PRICE SENSITIVE	18/12/14	88.27KB	Share
ACW	Section 708A Notice		15/12/14	28.54KB	Share
ACW	Appendix 3B		15/12/14	144.19KB	Share
ACW	Actinogen Medical Appoints Dr Bill Ketelbey as CEO	PRICE SENSITIVE	15/12/14	130.59KB	Share
ACW	Details of Company Address		08/12/14	99.85KB	Share
ACW	Becoming a substantial holder		08/12/14	108.72KB	Share
ACW	Section 708A Notice		08/12/14	28.4KB	Share
ACW	Becoming a substantial holder		05/12/14	60.32KB	Share
ACW	Becoming a substantial holder		05/12/14	35.86KB	Share
ACW	Appendix 3Y-Dr Brendan de Kauwe		04/12/14	23.99KB	Share
ACW	Appendix 3X-Dr Jason Loveridge		04/12/14	65.45KB	Share
ACW	Appendix 3Y-Dr Anton Uvarov		04/12/14	23.92KB	Share
ACW	Appendix 3X-Mr Martin Rogers		04/12/14	65.41KB	Share
ACW	Final Director's Interest Notice		04/12/14	18.33KB	Share
ACW	Appendix 3B		03/12/14	144.58KB	Share
ACW	AusBiotech Invest Presentation 2014		03/12/14	930.58KB	Share
ACW	Section 708A Notice		02/12/14	28.64KB	Share
ACW	Actinogen Completes Acquisition of Corticrine Limited		01/12/14	260.81KB	Share
ACW	R&D Tax Rebate Received	PRICE SENSITIVE	01/12/14	68.09KB	Share
ACW	Results of Annual General Meeting		19/11/14	60.38KB	Share
ACW	New Patents Allowed for B-HSD1 Inhibitor	PRICE SENSITIVE	05/11/14	110.05KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	23/10/14	189.62KB	Share
ACW	Annual Report to shareholders		16/10/14	1.19MB	Share
ACW	Notice of Annual General Meeting/Proxy Form		16/10/14	1.06MB	Share
ACW	Appointment of Vice President of Clinical Research		12/09/14	54.27KB	Share
ACW	Change in Substantial Shareholding x 3		03/09/14	2.08MB	Share
ACW	Information Required under Asx Listing Rule 3.10.5A		02/09/14	30.58KB	Share
ACW	Section 708A Notice		02/09/14	28.39KB	Share
ACW	Appendix 3B -Share Placement		02/09/14	144.74KB	Share
ACW	Investor Presentation		27/08/14	1.33MB	Share
ACW	Appointment of Clinical Advisers		27/08/14	83.22KB	Share
ACW	Proposed Board Changes		27/08/14	66.1KB	Share
ACW	Capital Raising	PRICE SENSITIVE	27/08/14	52.26KB	Share
ACW	Actinogen to acquire Corticrine Limited	PRICE SENSITIVE	27/08/14	171.53KB	Share
ACW	Trading Halt	PRICE SENSITIVE	26/08/14	106.11KB	Share
ACW	Appendix 4E & Financial Statements	PRICE SENSITIVE	01/08/14	1.22MB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	31/07/14	140.87KB	Share
ACW	Actinogen Isolates Demonstrate Antitumorigenic Activity	PRICE SENSITIVE	13/06/14	40.6KB	Share
ACW	Replacement Securities Trading Policy		23/04/14	121.07KB	Share
ACW	Dr Brendan de Kauwe Appointed Executive Chairman		23/04/14	26.55KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	16/04/14	131.49KB	Share
ACW	Section 708A Notice		10/04/14	27.62KB	Share
ACW	Appendix 3B - Exercise of Unlisted Options		10/04/14	135.58KB	Share
ACW	Investor Presentation		18/03/14	584.1KB	Share
ACW	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	27/02/14	504.02KB	Share
ACW	Actinogen & Curtin Uni to Work on Cancer Stem Cells	PRICE SENSITIVE	27/02/14	34.07KB	Share
ACW	TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT	PRICE SENSITIVE	12/02/14	115.11KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	23/01/14	107.89KB	Share
ACW +FGH	Actinogen Ltd Collaboration	PRICE SENSITIVE	23/12/13	492.26KB	Share
ACW +FGH	Leaf to Fund First Trial on Actingoen's Bioethanol Project	PRICE SENSITIVE	23/12/13	34.84KB	Share
ACW	Actinogen Establishes New Laboratory		19/12/13	28.45KB	Share
ACW	Final Director's Interest Notice		17/12/13	16.8KB	Share
ACW	Appendix 3X - Dr Anton Uvarov		16/12/13	61.59KB	Share
ACW	Appointment of Non-Executive Director		16/12/13	29.8KB	Share
ACW	Initial Substantial Shareholders Notices x 3		16/12/13	1.44MB	Share
ACW	Appendix 3Y - Mr Daniel Parasiliti		12/12/13	21.87KB	Share
ACW	Appendix 3Y - Dr Brendan de Kauwe		12/12/13	22KB	Share
ACW	Placement, Appendix 3B & Section 708A Notice	PRICE SENSITIVE	12/12/13	195.94KB	Share
ACW	Consolidation of Capital Completed		10/12/13	32.88KB	Share
ACW	Consoldiation Update		03/12/13	31.51KB	Share
ACW	Constitution		29/11/13	404.68KB	Share
ACW	Results of Meeting		29/11/13	49.95KB	Share
ACW	R&D Tax Rebate Received	PRICE SENSITIVE	28/11/13	44.9KB	Share
ACW	David Zohar to Resign as a Director		26/11/13	26.75KB	Share
ACW	Executive Director Appointment		19/11/13	29.18KB	Share
ACW	Activity Report & Appendix 4C	PRICE SENSITIVE	29/10/13	127.53KB	Share
ACW	Annual Report to Shareholders		28/10/13	2.47MB	Share
ACW	Notice of Annual General Meeting/Proxy Form		28/10/13	311.07KB	Share
ACW	Appointment of Scientific Consultant		28/10/13	27.71KB	Share
ACW	Change of Share Registry		18/10/13	74.06KB	Share
ACW	Details of Company Address		16/10/13	90.68KB	Share
ACW	Change of Company Secretary		11/10/13	213.37KB	Share
ACW	Placement of Shares, Appendix 3B and Section 708A Notice		08/10/13	1.12MB	Share
ACW	Initial Director's Interest Notice		26/09/13	196.61KB	Share
ACW	Initial Director's Interest Notice		26/09/13	196.8KB	Share
ACW	Final Director's Interest Notice		24/09/13	76.14KB	Share
ACW	Final Director's Interest Notice		24/09/13	76.59KB	Share
ACW	Final Director's Interest Notice		24/09/13	75.59KB	Share
ACW	Final Director's Interest Notice		24/09/13	76.44KB	Share
ACW	Signing of loan agreement and change of Board		24/09/13	100.18KB	Share
ACW	Closure of laboratory	PRICE SENSITIVE	12/09/13	57.22KB	Share
ACW	Annual Report to shareholders		12/09/13	2.7MB	Share
ACW	Actinogen to receive further funding from Otsana Capital	PRICE SENSITIVE	11/09/13	87.74KB	Share
ACW	Preliminary Final Report	PRICE SENSITIVE	30/08/13	183.66KB	Share
ACW	Market Update and Clarification	PRICE SENSITIVE	29/08/13	1.2MB	Share
ACW	Suspension of ACWN and ACWO 1/08/13	PRICE SENSITIVE	01/08/13	79.81KB	Share
ACW	Letter to Shareholders		31/07/13	4.56MB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	144.03KB	Share
ACW	Supplementary prospectus - withdrawal of offer	PRICE SENSITIVE	31/07/13	121.26KB	Share
ACW	Change of Director's Interest Notice - Z Pervan		10/07/13	110.44KB	Share
ACW	Change of Director's Interest Notice - Z Pervan		03/07/13	110.52KB	Share

ACW Investor Presentation-February 2015
17/02/15		1.06MB	Share
ACW Investor Update-February 2015
16/02/15		5.19MB	Share
ACW Ethics Approval Granted for Second Phase 1 Study of Xanamem
16/02/15	PRICE SENSITIVE	106.82KB	Share
ACW Appendix 4C - quarterly
29/01/15	PRICE SENSITIVE	89.07KB	Share
ACW Employee Share Plan Vesting Conditions Met
16/01/15		88.05KB	Share
ACW US Investor Presentation-January 2015
09/01/15		1.63MB	Share
ACW Resonse to ASX Query - Price Query
07/01/15	PRICE SENSITIVE	137.48KB	Share
ACW Final Director's Interest Notice
18/12/14		18.57KB	Share
ACW Appendix 3X-Dr Bill Ketelbey
18/12/14		66.02KB	Share
ACW Actinogen Board Changes
18/12/14	PRICE SENSITIVE	88.27KB	Share
ACW Section 708A Notice
15/12/14		28.54KB	Share
ACW Appendix 3B
15/12/14		144.19KB	Share
ACW Actinogen Medical Appoints Dr Bill Ketelbey as CEO
15/12/14	PRICE SENSITIVE	130.59KB	Share
ACW Details of Company Address
08/12/14		99.85KB	Share
ACW Becoming a substantial holder
08/12/14		108.72KB	Share
ACW Section 708A Notice
08/12/14		28.4KB	Share
ACW Becoming a substantial holder
05/12/14		60.32KB	Share
ACW Becoming a substantial holder
05/12/14		35.86KB	Share
ACW Appendix 3Y-Dr Brendan de Kauwe
04/12/14		23.99KB	Share
ACW Appendix 3X-Dr Jason Loveridge
04/12/14		65.45KB	Share
ACW Appendix 3Y-Dr Anton Uvarov
04/12/14		23.92KB	Share
ACW Appendix 3X-Mr Martin Rogers
04/12/14		65.41KB	Share
ACW Final Director's Interest Notice
04/12/14		18.33KB	Share
ACW Appendix 3B
03/12/14		144.58KB	Share
ACW AusBiotech Invest Presentation 2014
03/12/14		930.58KB	Share
ACW Section 708A Notice
02/12/14		28.64KB	Share
ACW Actinogen Completes Acquisition of Corticrine Limited
01/12/14		260.81KB	Share
ACW R&D Tax Rebate Received
01/12/14	PRICE SENSITIVE	68.09KB	Share
ACW Results of Annual General Meeting
19/11/14		60.38KB	Share
ACW New Patents Allowed for B-HSD1 Inhibitor
05/11/14	PRICE SENSITIVE	110.05KB	Share
ACW Appendix 4C & Commentary
23/10/14	PRICE SENSITIVE	189.62KB	Share
ACW Annual Report to shareholders
16/10/14		1.19MB	Share
ACW Notice of Annual General Meeting/Proxy Form
16/10/14		1.06MB	Share
ACW Appointment of Vice President of Clinical Research
12/09/14		54.27KB	Share
ACW Change in Substantial Shareholding x 3
03/09/14		2.08MB	Share
ACW Information Required under Asx Listing Rule 3.10.5A
02/09/14		30.58KB	Share
ACW Section 708A Notice
02/09/14		28.39KB	Share
ACW Appendix 3B -Share Placement
02/09/14		144.74KB	Share
ACW Investor Presentation
27/08/14		1.33MB	Share
ACW Appointment of Clinical Advisers
27/08/14		83.22KB	Share
ACW Proposed Board Changes
27/08/14		66.1KB	Share
ACW Capital Raising
27/08/14	PRICE SENSITIVE	52.26KB	Share
ACW Actinogen to acquire Corticrine Limited
27/08/14	PRICE SENSITIVE	171.53KB	Share
ACW Trading Halt
26/08/14	PRICE SENSITIVE	106.11KB	Share
ACW Appendix 4E & Financial Statements
01/08/14	PRICE SENSITIVE	1.22MB	Share
ACW Appendix 4C & Commentary
31/07/14	PRICE SENSITIVE	140.87KB	Share
ACW Actinogen Isolates Demonstrate Antitumorigenic Activity
13/06/14	PRICE SENSITIVE	40.6KB	Share
ACW Replacement Securities Trading Policy
23/04/14		121.07KB	Share
ACW Dr Brendan de Kauwe Appointed Executive Chairman
23/04/14		26.55KB	Share
ACW Appendix 4C & Commentary
16/04/14	PRICE SENSITIVE	131.49KB	Share
ACW Section 708A Notice
10/04/14		27.62KB	Share
ACW Appendix 3B - Exercise of Unlisted Options
10/04/14		135.58KB	Share
ACW Investor Presentation
18/03/14		584.1KB	Share
ACW Appendix 4D & Half-Year Financial Statements
27/02/14	PRICE SENSITIVE	504.02KB	Share
ACW Actinogen & Curtin Uni to Work on Cancer Stem Cells
27/02/14	PRICE SENSITIVE	34.07KB	Share
ACW TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT
12/02/14	PRICE SENSITIVE	115.11KB	Share
ACW Appendix 4C & Commentary
23/01/14	PRICE SENSITIVE	107.89KB	Share
ACW +FGHActinogen Ltd Collaboration
23/12/13	PRICE SENSITIVE	492.26KB	Share
ACW +FGHLeaf to Fund First Trial on Actingoen's Bioethanol Project
23/12/13	PRICE SENSITIVE	34.84KB	Share
ACW Actinogen Establishes New Laboratory
19/12/13		28.45KB	Share
ACW Final Director's Interest Notice
17/12/13		16.8KB	Share
ACW Appendix 3X - Dr Anton Uvarov
16/12/13		61.59KB	Share
ACW Appointment of Non-Executive Director
16/12/13		29.8KB	Share
ACW Initial Substantial Shareholders Notices x 3
16/12/13		1.44MB	Share
ACW Appendix 3Y - Mr Daniel Parasiliti
12/12/13		21.87KB	Share
ACW Appendix 3Y - Dr Brendan de Kauwe
12/12/13		22KB	Share
ACW Placement, Appendix 3B & Section 708A Notice
12/12/13	PRICE SENSITIVE	195.94KB	Share
ACW Consolidation of Capital Completed
10/12/13		32.88KB	Share
ACW Consoldiation Update
03/12/13		31.51KB	Share
ACW Constitution
29/11/13		404.68KB	Share
ACW Results of Meeting
29/11/13		49.95KB	Share
ACW R&D Tax Rebate Received
28/11/13	PRICE SENSITIVE	44.9KB	Share
ACW David Zohar to Resign as a Director
26/11/13		26.75KB	Share
ACW Executive Director Appointment
19/11/13		29.18KB	Share
ACW Activity Report & Appendix 4C
29/10/13	PRICE SENSITIVE	127.53KB	Share
ACW Annual Report to Shareholders
28/10/13		2.47MB	Share
ACW Notice of Annual General Meeting/Proxy Form
28/10/13		311.07KB	Share
ACW Appointment of Scientific Consultant
28/10/13		27.71KB	Share
ACW Change of Share Registry
18/10/13		74.06KB	Share
ACW Details of Company Address
16/10/13		90.68KB	Share
ACW Change of Company Secretary
11/10/13		213.37KB	Share
ACW Placement of Shares, Appendix 3B and Section 708A Notice
08/10/13		1.12MB	Share
ACW Initial Director's Interest Notice
26/09/13		196.61KB	Share
ACW Initial Director's Interest Notice
26/09/13		196.8KB	Share
ACW Final Director's Interest Notice
24/09/13		76.14KB	Share
ACW Final Director's Interest Notice
24/09/13		76.59KB	Share
ACW Final Director's Interest Notice
24/09/13		75.59KB	Share
ACW Final Director's Interest Notice
24/09/13		76.44KB	Share
ACW Signing of loan agreement and change of Board
24/09/13		100.18KB	Share
ACW Closure of laboratory
12/09/13	PRICE SENSITIVE	57.22KB	Share
ACW Annual Report to shareholders
12/09/13		2.7MB	Share
ACW Actinogen to receive further funding from Otsana Capital
11/09/13	PRICE SENSITIVE	87.74KB	Share
ACW Preliminary Final Report
30/08/13	PRICE SENSITIVE	183.66KB	Share
ACW Market Update and Clarification
29/08/13	PRICE SENSITIVE	1.2MB	Share
ACW Suspension of ACWN and ACWO 1/08/13
01/08/13	PRICE SENSITIVE	79.81KB	Share
ACW Letter to Shareholders
31/07/13		4.56MB	Share
ACW Appendix 4C - quarterly
31/07/13	PRICE SENSITIVE	144.03KB	Share
ACW Supplementary prospectus - withdrawal of offer
31/07/13	PRICE SENSITIVE	121.26KB	Share
ACW Change of Director's Interest Notice - Z Pervan
10/07/13		110.44KB	Share
ACW Change of Director's Interest Notice - Z Pervan
03/07/13		110.52KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.8¢		Change 0.001(3.70%)		Mkt cap ! $90.50M

Open	High	Low	Value	Volume
2.8¢	2.9¢	2.8¢	$67.97K	2.391M

Buyers (Bids)

No.	Vol.	Price($)
7	1278638	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	250406	4

View Market Depth

No.	Vol.	Price($)
7	1278638	0.028
5	2499560	0.027
5	2610855	0.026
14	2431589	0.025
8	2261655	0.024

Price($)	Vol.	No.
0.029	250406	4
0.030	3856464	10
0.031	539999	3
0.032	2534250	7
0.033	981127	8

Last trade - 15.21pm 11/09/2025 (20 minute delay)


Last 2.9¢		Change 0.001 ( 3.64 %)
Open	High	Low	Volume
2.9¢	2.9¢	2.8¢	448096
Last updated 15.17pm 11/09/2025 ?

ACW (ASX) Chart

ACTINOGEN MEDICAL LIMITED - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories